What is PAHC's health score?

PHIBRO ANIMAL HEALTH CORP (PAHC) has a TradeApes health score of 69 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PAHC's estimated fair value?

Based on our 5-year discounted cash flow model, PHIBRO ANIMAL HEALTH CORP's estimated fair value is $24.69 per share, representing a -25.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is PAHC undervalued or overvalued?

Our model currently rates PAHC as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for PAHC... Refresh in a moment for the full analysis.

PHIBRO ANIMAL HEALTH CORP (PAHC)

Healthcare Overvalued low healthy

$33.04

Updated: 2026-06-05

TradeApes Score

Financial Strength

80 Strong

Operating Trend

60 Healthy

Relative Value

75 Strong

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $24.69

DCF Upside -25.3%

Sector Rank #816 of 6654

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− FCF deteriorating — free cash flow down more than 25% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.